Philip C. Hoffman

4.3k citations
82 papers · 3.2k · 2 hit papers · h-index 29

Impact in

    • Lung Cancer Treatments and Mutations
    • Lung Cancer Diagnosis and Treatment
    • Brain Metastases and Treatment
  • Oncology top 2%
    • Lung Cancer Research Studies
    • Cancer Immunotherapy and Biomarkers

Papers in

Philip C. Hoffman

80 papers receiving 3.0k citations

Philip C. Hoffman's Hit Papers

Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non–Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial 2015 · 289 citations
2890+8+17Years since publication100200300400500

Peers

Philip C. Hoffman
Comparison fields: 5 of 138
  • Pulmonary and Respiratory Medicine 1.4k
  • Oncology 991
  • Cancer Research 263
  • Hematology 142
  • Museology 40
Replace Rebecca Slack with:
Rebecca Slack United States
Fiona Stewart Netherlands
M. Bamberg Germany
Roger M. Macklis United States
James M. Larner United States
Karol Sikora United Kingdom
Eric T. Shinohara United States
Jenna Sykes Canada
Diane D. Liu United States
Ted A.W. Splinter Netherlands
Philip C. Hoffman relative to Rebecca Slack United States Rebecca Slack's profile →
Citations per field
00.5×1.5×2.2×
Rebecca Slack · 1×
Citations per year

Countries citing papers authored by Philip C. Hoffman

Since Specialization
Citations

This map shows the geographic impact of Philip C. Hoffman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip C. Hoffman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip C. Hoffman more than expected).

Fields of papers citing papers by Philip C. Hoffman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip C. Hoffman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip C. Hoffman. The network helps show where Philip C. Hoffman may publish in the future.

Co-authors

The 25 scholars most cited alongside Philip C. Hoffman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philip C. Hoffman Line = papers co-authored together Philip C. Hoffman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Lung cancer
Hit paper breakdown →
2000530
2
Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non–Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial
Hit paper breakdown →
2015289
3 2011259
4 2004121
5 2014116
6 2000109
7 201185
8 202183
9 200671
10 201968
11 200767
12 198360
13 197757
14 200856
15 201255
16 197950
17 198450
18 198748
19 198747
20 198643

About Philip C. Hoffman

Philip C. Hoffman is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Epidemiology and Molecular Biology, having authored 82 papers that have together received 3.2k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (33 papers), Lung Cancer Diagnosis and Treatment (29 papers), Lung Cancer Research Studies (19 papers), Cancer Genomics and Diagnostics (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Neuroendocrine Tumor Research Advances (5 papers), Platelet Disorders and Treatments (4 papers) and Esophageal Cancer Research and Treatment (4 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.4k citations), Oncology (991 citations), Cancer Research (263 citations), Hematology (142 citations) and Museology (40 citations). Philip C. Hoffman has collaborated with scholars based in United States, Germany and Taiwan. Frequent co-authors include Everett E. Vokes, Ann M. Mauer, Harvey M. Golomb, Alex G. Little, Daniel J. Haraf, Mark K. Ferguson, Jacob D. Bitran, Ralph R. Weichselbaum, Tom R. DeMeester and Livia L. Szeto. Their work appears in journals such as Cancer, Journal of Clinical Oncology, Journal of Thoracic Oncology, The Annals of Thoracic Surgery and Journal of Thoracic and Cardiovascular Surgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact